key: cord-0831511-c8tqlx26
authors: Cafarotti, Stefano; Patella, Miriam
title: LUNG CANCER SURGICAL MANAGEMENT DURING THE OUTBREAK OF COVID-19
date: 2020-04-11
journal: J Thorac Oncol
DOI: 10.1016/j.jtho.2020.03.027
sha: d7ed8e5c6ba7494e0791f0c68ac5a2f291a36116
doc_id: 831511
cord_uid: c8tqlx26

nan

The outbreak of 2019 novel coronavirus (COVID-19) has ben declared a pandemic spread by the World Health Organization on March 11 2020. Some countries have been hit earlier and with lightning violence, leading to the collapse of health facilities and putting public health to the test.

The epidemiological and social emergency puts at risk of under-treatment not only patients with acute infections, but also health care pathways for other diseases. Diagnostic tests and hospital facilities are largely utilized for COVID-19 patients and most of resources are invested in this field.

However, it is our duty, as surgical specialists, not to forget our patients, especially cancer patients.

What it is happening to the lung cancer pathways of referral and treatment? For how long do we have to face this emergency? What will be the cost in terms of lung cancer-related death in this scenario?

It is a management and ethics dilemma and the answer is not easy to find in absence of evidences 

A War on Two Fronts: Cancer Care in the Time of COVID-19